You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematologic Neoplasms

Showing 26 - 50 of 3,797
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancies Trial in Assiut (CD56)

Recruiting
  • Hematologic Malignancies
  • CD56
  • Assiut, Egypt
  • +1 more
Jul 20, 2022

Immune Profiling for Cancer Immunotherapy Response

Recruiting
  • Cancer
  • +3 more
  • Methylation Cytometry
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Nov 6, 2023

Oral Complications in Hematological Malignancies

Not yet recruiting
  • Hematologic Malignancy
    • Assiut, Egypt
      Assiut university
    Mar 6, 2023

    Hematologic Malignancy Trial in Zhejiang (IBI322)

    Recruiting
    • Hematologic Malignancy
    • IBI322
    • Zhejiang, China
      The Second Affiliated Hospital Zhejiang University School of Med
    Sep 12, 2022

    Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

    Recruiting
    • Hematologic Malignancy
    • Stem Cell Transplant Complications
    • Beijing protocol
    • Beijing, Beijing, China
      Deparment of Hematology, Peking University People's Hospital
    Jun 19, 2023

    Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

    Recruiting
    • Hematological Malignancy
    • Cancer-Related Anemia
    • Shengxuening Tablet
    • Ferrous succinate
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Mar 13, 2023

    Hematologic Malignancies, Patient Participation Trial in Istanbul (Lavander oil Aromatherapy, Saline Solution)

    Recruiting
    • Hematologic Malignancies
    • Patient Participation
    • Lavander oil Aromatherapy
    • Saline Solution
    • Istanbul, Küçükçekmece, Turkey
      Dilek Yildirim
    Mar 30, 2023

    After Adoptive Transfer of Genetically Modified Cell Products

    Recruiting
    • Relapsed Hematologic Malignancy
    • Refractory Hematologic Malignancy
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Feb 6, 2023

      Hematologic Cancer, Hematologic Malignancy Trial in Boston (CBT for Fatigue, Usual Care)

      Not yet recruiting
      • Hematologic Cancer
      • Hematologic Malignancy
      • CBT for Fatigue
      • Usual Care
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Feb 3, 2023

      Research-Action in Hematology From Hospitalization to Home

      Completed
      • Hematologic Cancer
      • additional follow-up extension at home
      • Caen, France
        CAEN University Hospital
      Sep 22, 2023

      Hematologic Malignancy, Lymphoma Trial (Home-based training, Center-based training)

      Not yet recruiting
      • Hematologic Malignancy
      • Lymphoma
      • Home-based training
      • Center-based training
      • (no location specified)
      Mar 20, 2023

      Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

      Recruiting
      • Non-hodgkin Lymphoma
      • +2 more
      • CC312
      • Tianjin, Tianjin, China
        InstituteHBDH
      Sep 12, 2023

      Hematologic Malignancies Trial in Los Angeles (Cyclophosphamide)

      Not yet recruiting
      • Hematologic Malignancies
      • Los Angeles, California
        Cedars-Sinai Medical Center
      May 5, 2023

      Venous Thromboembolism in Hematologic Malignancy and

      Active, not recruiting
      • Thrombosis, Venous
      • +4 more
        • Toronto, Ontario, Canada
          Federico Carini
        Nov 21, 2022

        Patient Fitness and Body Composition During Hematopoietic Stem

        Active, not recruiting
        • Hematologic Malignancy
        • Observational
        • Seattle, Washington
          VA Puget Sound Health Care System
        Aug 2, 2022

        Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

        Not yet recruiting
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +2 more
        • Orange, California
          Chao Family Comprehensive Cancer Center, University of Californi
        Aug 31, 2023

        Hematologic Malignancy Trial in Tianjin (BR108 injection)

        Recruiting
        • Hematologic Malignancy
        • BR108 injection
        • Tianjin, Tianjin, China
          Tianjin Medical University Cancer Institute and Hospital
        Aug 25, 2023

        Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

        Not yet recruiting
        • Advanced Systemic Mastocytosis
        • (no location specified)
        Nov 2, 2022

        Hematologic Malignancy Trial in Boston (PATH-C)

        Not yet recruiting
        • Hematologic Malignancy
        • PATH-C
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Nov 23, 2023

        Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

        Not yet recruiting
        • Multiple Myeloma
        • +2 more
        • Discontinuation of maintenance treatment
        • Cork, Ireland
          Cork University Hospital
        May 10, 2023

        Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

        Not yet recruiting
        • Aggressive B-Cell Non-Hodgkin's Lymphoma
        • +4 more
        • (no location specified)
        Dec 16, 2022

        NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

        Recruiting
        • NHL
        • +6 more
        • Minneapolis, Minnesota
        • +2 more
        Nov 7, 2023

        Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

        Recruiting
        • Acute Lymphoblastic Leukemia
        • +2 more
        • allogenic CD19-CAR-NK cells
        • Xuzhou, Jiangsu, China
          The Affiliated Hospital of Xuzhou Medical University
        Feb 11, 2023

        Hematologic Malignancy Trial in Nanchang, Jinan (TQB3702 tablets)

        Not yet recruiting
        • Hematologic Malignancy
        • TQB3702 tablets
        • Nanchang, Jiangxi, China
        • +1 more
        Nov 2, 2022

        Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia Trial in Birmingham

        Recruiting
        • Multiple Myeloma
        • +2 more
          • Birmingham, Alabama
            Kirklin Clinic of UAB Hospital
          Sep 22, 2022